MTD
Mettler-Toledo International Inc. · Healthcare · Medical - Diagnostics & Research
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 53.78K | $81.23M | n/a | n/a |
| Q2 2026 | 160 | +3 | 14.90M | $19.03B | +6 | −4 |
| Q1 2026 | 161 | 0 | 14.22M | $18.04B | +7 | −8 |
| Q4 2025 | 160 | 0 | 15.72M | $21.91B | +2 | −1 |
| Q3 2025 | 19 | +2 | 8.06M | $9.89B | +2 | −1 |
| Q2 2025 | 15 | -4 | 7.17M | $8.42B | n/a | −4 |
| Q1 2025 | 16 | 0 | 2.78M | $3.28B | n/a | n/a |
| Q4 2024 | 16 | -1 | 2.66M | $3.25B | n/a | −1 |
| Q3 2024 | 16 | 0 | 1.76M | $2.64B | n/a | n/a |
| Q2 2024 | 16 | n/a | 1.72M | $2.40B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 543.27K | n/a | $757.86M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 2 | T. Rowe Price ✦ | 348.08K | n/a | $486.48M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 284.76K | n/a | $397.98M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 181.13K | n/a | $253.14M | 0.2% | n/c | 1 | SEC ↗ ×4 |
| 5 | Wellington Management ✦ | 151.52K | n/a | $211.76M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 6 | Marshall Wace ✦ | 84.31K | n/a | $117.83M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 37.70K | n/a | $52.69M | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 26.71K | n/a | $37.33M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 17.54K | n/a | $24.51M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 17.41K | n/a | $24.33M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | Renaissance Technologies ✦ | 12.73K | n/a | $17.79M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 6.15K | n/a | $8.60M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 3.62K | n/a | $5.07M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | Gotham Asset Management ✦ | 2.50K | n/a | $3.49M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 2.20K | n/a | $3.08M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 1.16K | n/a | $1.62M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 815 holders, 19.62M shares, $23.18B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 942 sh · $1.34M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology